logo
Save Your Relationship: Get Better Sleep With the Scandinavian Sleep Method

Save Your Relationship: Get Better Sleep With the Scandinavian Sleep Method

CNET07-06-2025
Picture this: You've lain down for the evening, you're comfortable and cozy, you drift off... only to wake up in the middle of the night with no blankets because your partner has stolen them all while snoozing away next to you. Different people have different sleep needs, and a whopping one-third of Americans report that their partner has negatively affected their sleep. A recent CNET survey shows that 6 in 10 adults have considered changing their setup to ensure a good night's rest. The Scandinavian sleep method isn't a cure for snoring, but it can help if you're cuddling with a blanket hog.
If you're at your breaking point with sharing a bed but don't want to end up in a sleep divorce, trying a practice from Scandinavian countries might help. This solution may drastically improve your and your partner's sleep -- and relationship. So, how does the Scandinavian sleep method work? Here's what to know.
Also, don't miss our editors' favorite sleep tips, how to tackle anxiety before bed and whether tech can help you sleep better.
What is the Scandinavian sleep method?
The Scandinavian sleep method is common practice in certain regions of the world, including Sweden, Norway, Denmark and other parts of Europe. The idea is simple: Instead of sharing a blanket at night, you and your partner each have your own. It's not about avoiding intimacy or sacrificing part of your relationship. It's about prioritizing your sleep needs so that both of you can wake up well-rested and energized.
Most people use two twin-size comforters or duvets for the Scandinavian sleep method. This sleeping style typically works best on king mattresses, which give the separate blankets the most room, but queen mattresses work fine for most people.
Traditionally, you forgo the shared flat sheet for this. If you're like me and love flat sheets, you can always opt for two flat sheets in addition to separate blankets. There's no right or wrong way to do it.
What are the benefits of the Scandinavian sleep method?
The main benefits of the Scandinavian sleep method are more quality sleep and less strain on your relationship. Getting restful shuteye positively impacts overall health and wellness, from immune support to coping with daily stressors.
Promotes better sleep quality
Reduces the number of sleep disturbances
Allows for an individualistic sleep setup
Encourages better temperature regulation
Can create a more relaxing environment
Co-sleeping; don't have to resort to sleep divorce
Can help prevent unnecessary stress or strain in your relationship
Two comforters can help you sleep better
Sharing a comforter with your partner might not be the best option for your needs, and that's OK. Sleep is inherently a single-player sport. It's not something you are required to share with your partner. For many, sharing a blanket might not be the best move for your sleep quality. One study found that sharing comforters results in 30% more interrupted sleep.
By each having their own blanket, the half-asleep tug-of-war battle is eliminated, and so are all the times you wake up because you're cold and blanketless. You also can adjust positions at night without worrying about affecting your partner.
Remember that the Scandinavian sleep method isn't reserved just for those who live with a blanket hog. It's a good option for anyone who tosses and turns or has a different sleeping pattern that may wake up their partner.
In her video, YouTuber Cecilia Blomdahl demonstrates this method and explains the Scandinavian culture around sleep.
Cecilia Blomdahl/YouTube
For a visual representation, watch Swedish NYT bestselling author and popular YouTuber Cecilia Blomdahl explain the Scandinavian sleep method from her remote cabin in Svalbard, near the North Pole.
From Memory Foam to Hybrids: The Best Mattresses You Can Buy According to Our Experts
+14 More
See all photos
Comforters vs. duvets
Comforters and duvets are fluffy blankets that come in various thicknesses and materials for temperature regulation. A comforter is one complete piece, while a duvet is meant to be inserted into a cover or coverlet.
Duvet covers are interchangeable, so you can easily alter the look of your bed without buying a whole new comforter set. Duvets are also easier to clean because you can remove and wash the cover. Comforters are easier to use because they're one blanket with no cover. They're usually quilted or stitched so that the material inside is secure and evenly distributed. You won't have "bunching up" issues with comforters like you might with a duvet in its cover.
Which one should you use?
For the Scandinavian sleep method, both duvets and comforters work great as long as each partner uses their own. If I had to choose between the two options, I would recommend comforters for their simplicity. Using two duvets means you'll have double the work of reinserting them into their respective covers every time you wash the bedding, which can be awkward and time-consuming. Ultimately, it's up to your preferences and whatever will help you and your partner sleep best.
The Scandinavian sleep method lets you say goodbye to the nightly blanket battle.
Skynesher/Getty Images
You can personalize your sleep experience
When my boyfriend is asleep, he turns into an (almost literal) pool of lava, kicking off the blanket to cool down. I'm not like that; I like to burrow into my blanket all night.
Having two blankets allows for personalization in temperature. Temperature is essential when we sleep; it triggers when we fall asleep and wake up. Getting too warm or too cold will interrupt our circadian rhythm.
If your partner is a hot sleeper who only wants to use a sheet while you like to wrap in a comforter burrito, then you have that freedom with separate bedding. You have the choice to use a quilt, fuzzy blanket or light duvet, while your partner could use nothing at all -- or something more substantial, like a weighted blanket.
Throughout their couple's mattress testing series, CNET video producer Dillon and writer Aly have discussed resorting to the Scandinavian sleep method a few times.
"If we anticipate one of us will likely toss and turn for whatever reason, Dillon and I use the Scandinavian sleep method. We keep extra comforters and blankets in the bedroom to grab if one person is being annoying -- whether hogging the blankets or kicking them all off. It makes a huge difference," Aly says.
You can place another blanket or quilt over the separate covers (also known as an overcast) to make the bed look cohesive.
Aly Lopez/CNET
Will two blankets solve all of your problems?
If your sleep problems are due to your or your partner's underlying sleep disorder, using two blankets won't solve everything, although it can help protect you from additional sleep disturbances. Sleep is essential for health. When we sleep, our bodies go into recharge mode. Getting enough sleep will result in better memory and concentration, a stronger immune system and better heart health. If you're not getting enough sleep at night, it's important to figure out why.
Read more: Best Mattresses for Good Sleep
It may be as simple as using the wrong pillow or sleeping on a mattress that's too old and needs to be replaced. It could be something more serious like sleep apnea or insomnia that can significantly disturb your sleep. It's best to talk to your doctor if you're not sleeping well to explore the underlying causes.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Maziar Mike Doustdar appointed as president and chief executive officer of Novo Nordisk
Maziar Mike Doustdar appointed as president and chief executive officer of Novo Nordisk

Yahoo

time17 hours ago

  • Yahoo

Maziar Mike Doustdar appointed as president and chief executive officer of Novo Nordisk

Bagsværd, Denmark, 29 July 2025 – Novo Nordisk today announced that Maziar Mike Doustdar has been appointed as president and chief executive officer, effective 7 August 2025. Mike Doustdar succeeds Lars Fruergaard Jørgensen, who will step down as president and chief executive officer on the same date. The company also announced other executive-level changes, effective 7 August. Mike Doustdar, currently Novo Nordisk's executive vice president of International Operations, has a strong track record of creating value and driving growth. Under his leadership over the past decade, Novo Nordisk's International Operations have more than doubled sales to approximately DKK 112 billion in 2024. The business includes all of Novo Nordisk's affiliates outside of the US and employs nearly 20,000 people. Novo Nordisk Chair, Helge Lund, said: 'Mike is an exceptional leader and has the unanimous support of the Board. We are confident that he is the best person to lead Novo Nordisk through its next growth phase. Mike has consistently demonstrated the ability to drive growth through strong commercial execution and building high-performing teams. This is an important moment for Novo Nordisk. The market is developing rapidly, and the company needs to address recent market challenges with speed and ambition. I believe Novo Nordisk will build on its strengths as a global leader in obesity and diabetes, and Mike has a clear vision of how to unlock the full potential of the opportunities ahead.' Mike Doustdar has been appointed as the result of a comprehensive process that included external and internal candidates. The Novo Nordisk Foundation fully endorses Novo Nordisk Board's decision to appoint Maziar Mike Doustdar as president and chief executive officer. Mike Doustdar said: 'It's an enormous privilege to lead this company at a time of tremendous opportunity and change. I come to this role with a sense of urgency, a laser focus on high performance, and a fierce determination for Novo Nordisk to aim higher than it's ever done, and to deliver to many more patients the innovation they need. From my decades in leadership roles across Novo Nordisk, I know the extraordinary talent and commitment of our people and the excellence of our science. This has enabled us to achieve great things in the past and will ensure we continue to do so in the future.' Novo Nordisk Chair, Helge Lund, added: 'Under Lars's leadership, Novo Nordisk has undergone a profound period of growth and now reaches millions more patients with life-changing medicines. On behalf of Novo Nordisk's Board of Directors and our employees, I want to thank Lars for 34 years of unstinting commitment to the company and wish him all the best in his future endeavours.' Other organisational changes effective 7 August: Research & Early Development and Development EVP areas will be merged into a combined R&D Nordisk has decided to merge the company's Research & Early Development with its Development area into a new, consolidated R&D unit, under the leadership of Martin Holst Lange, MD, PhD. Martin Holst Lange, currently executive vice president, Development, will be appointed chief scientific officer (CSO), effective 7 August. Martin Holst Lange will focus on seamlessly combining the two functions, quickly advancing the innovation of new therapies and ensuring the success of the early and late-stage pipelines, with a significant focus on the diabetes and obesity areas. In addition, Martin Holst Lange will work closely with Mike Doustdar to drive pipeline development and innovation from both within and outside of the company. Marcus Schindler, executive vice president, Research & Early Development and CSO, has decided to retire from the company. Novo Nordisk Chair, Helge Lund, said: 'We thank Marcus for his deep commitment to Novo Nordisk and its pursuit of scientific excellence. We wish him all the best for the future.' Marcus Schindler joined Novo Nordisk in January 2018 as senior vice president of External Innovation and Strategy and has been CSO since 2021. Marcus Schindler has played an integral role in leading the discovery of early scientific innovation. He will remain at Novo Nordisk for a short period to ensure a successful transition. Emil Kongshøj Larsen, currently senior vice president of the Europe and Canada region (EUCAN), will join Executive Management and succeed Mike Doustdar, assuming the responsibility of executive vice president, International Operations. Emil Larsen currently leads a region spanning 40 countries, accounting for about 20% of Novo Nordisk's global sales. He has previously led other significant business areas throughout Europe, Africa and the Middle East, as well as Commercial Affairs and Strategy in International Operations. With these changes, Executive Management will have the following members, effective 7 August: Maziar Mike Doustdar, president and CEO* Thilde Hummel Bøgebjerg, EVP, Quality, IT & Environmental Affairs Emil Kongshøj Larsen, EVP, International Operations Ludovic Helfgott, EVP, Product & Portfolio Strategy Karsten Munk Knudsen, EVP, chief financial officer* Martin Holst Lange, EVP, chief scientific officer, Research & Development David Moore, EVP, US Operations Tania Sabroe, EVP, People, Organisation and Corporate Affairs Henrik Wulff, EVP, CMC & Product Supply * Registered as an executive with the Danish Business Authority. About Maziar Mike DoustdarMike Doustdar became senior vice president of International Operations in 2013, a business that includes 80 affiliates - all of Novo Nordisk's commercial affiliates outside of the US. Novo Nordisk's International Operations had sales of approximately DKK 112 billion in 2024 and serve approximately 35 million patients. Prior to this role, Mike led Novo Nordisk's Southeast Asia and Oceania commercial area out of Malaysia, following on from his leadership of the Middle East business. Prior to this, he was general manager based in Turkey and held leadership roles in finance and IT. Mike Doustdar became executive vice president in 2015. He is a member of the Board of Directors of Orion Corporation. Conference CallNovo Nordisk will host a conference call for investors at 14.30 CEST on 29 July 2025, corresponding to 8.30 am EST. For more information on how to listen, please visit the investor section of There will be a conference call for media at 16.00 CEST, which corresponds to 10.00 am EST. Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure disease. Novo Nordisk employs about 77,400 people in 80 countries and markets its products in around 170 countries. Novo Nordisk's B shares are listed on Nasdaq Copenhagen (Novo-B). Its ADRs are listed on the New York Stock Exchange (NVO). For more information, visit Facebook, Instagram, X, LinkedIn and YouTube. Contacts for further information Media: Ambre James-Brown +45 3079 9289abmo@ Liz Skrbkova (US)+1 609 917 0632lzsk@ Investors: Jacob Martin Wiborg Rode+45 3075 5956jrde@ Sina Meyer +45 3079 6656azey@ Max Ung+45 3077 6414 mxun@ Frederik Taylor Pitter +1 609 613 0568fptr@ Publication of inside information pursuant to Market Abuse Regulation, Article 17 Company announcement No 19 / 2025 Attachment CA250729-CEO-succession

Obesity drugmaker Novo Nordisk cuts 2025 sales growth, operating profit outlook
Obesity drugmaker Novo Nordisk cuts 2025 sales growth, operating profit outlook

Yahoo

time17 hours ago

  • Yahoo

Obesity drugmaker Novo Nordisk cuts 2025 sales growth, operating profit outlook

COPENHAGEN (Reuters) -Obesity drugmaker Novo Nordisk (NVO) warned on Tuesday that full-year sales and operating profit would grow less than previously expected, marking its second forecast cut of 2025. Novo stock fell 13% before the bell on Tuesday. The maker of weight-loss drug Wegovy is struggling to convince investors it can remain competitive in the obesity drug boom against U.S. rival Eli Lilly (LLY). Novo shares have fallen sharply over the past year. "The lowered sales outlook for 2025 is driven by lower growth expectations for the second half of 2025," the company said in a statement. "This is related to lower growth expectations for Wegovy in the U.S. obesity market, lower growth expectations for Ozempic in the U.S. GLP-1 diabetes market, as well as lower-than-expected penetration for Wegovy in select IO markets," it said. Novo now expects 2025 sales growth of 8%-14% in local currencies, down from its previous 13-21% range. It also lowered its operating profit growth forecast to 10%-16%, from a prior outlook of 16-24%. Sign up for Yahoo Finance Daily Movers By subscribing, you are agreeing to Yahoo's Terms and Privacy Policy Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Obesity drugmaker Novo Nordisk cuts 2025 sales growth, operating profit outlook
Obesity drugmaker Novo Nordisk cuts 2025 sales growth, operating profit outlook

Yahoo

time18 hours ago

  • Yahoo

Obesity drugmaker Novo Nordisk cuts 2025 sales growth, operating profit outlook

COPENHAGEN (Reuters) -Obesity drugmaker Novo Nordisk warned on Tuesday that full-year sales and operating profit would grow less than previously expected, marking its second forecast cut of 2025. The maker of weight-loss drug Wegovy is struggling to convince investors it can remain competitive in the obesity drug boom against U.S. rival Eli Lilly. Novo shares have fallen sharply over the past year. "The lowered sales outlook for 2025 is driven by lower growth expectations for the second half of 2025," the company said in a statement. "This is related to lower growth expectations for Wegovy in the U.S. obesity market, lower growth expectations for Ozempic in the U.S. GLP-1 diabetes market, as well as lower-than-expected penetration for Wegovy in select IO markets," it said. Novo now expects 2025 sales growth of 8%-14% in local currencies, down from its previous 13-21% range. It also lowered its operating profit growth forecast to 10%-16%, from a prior outlook of 16-24%. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store